Invest in Stille
There are solid opportunities for Stille to develop and acquire new products supported by underlying market trends and new technology innovations. Our focus on quality and innovation in all market segments, with strong potential for growth, will result in a stable and long-term return to our shareholders.
New surgical innovated techniques and an increased average lifespan are some of the factors that will affect the future trends in healthcare and will serve as the prerequisites for Stille’s sustainable growth.
Stille’s premium line of surgical instrumentation are currently used in all surgical procedures. Well known surgeons worldwide consider Stille instruments as an extension of their hand. When it comes to minimally invasive procedures, our ImagiQ2 and Medstone operating tables are the market leaders.